• Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Data Privacy
  • Sign Up
  • Send a Release
Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • News
  • Products
    • Overview
    • Content Distribution
    • Multimedia Services
    • Disclosure Services
    • Cision Communications Cloud®
  • Contact
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases
      • All Public Company News
      • All Multimedia News


      • View All News Releases
      • Regulatory News
      • D/A/CH Regulatory News
      • UK Regulatory News


      • View All Regulatory News
  • Business & Money
      • Auto & Transportation
      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation


      • View All Auto & Transportation
      • Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors


      • View All Business Technology
      • Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television


      • View All Entertain­ment & Media
      • Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Stock Offering
      • Stock Split
      • Venture Capital


      • View All Financial Services & Investing
      • General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News


      • View All General Business
  • Science & Tech
      • Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications


      • View All Consumer Technology
      • Energy & Natural Resources
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities


      • View All Energy & Natural Resources
      • Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters


      • View All Environ­ment
      • Heavy Industry & Manufacturing
      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco


      • View All Heavy Industry & Manufacturing
      • Telecomm­unications
      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications


      • View All Telecomm­unications
  • Lifestyle & Health
      • Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys


      • View All Consumer Products & Retail
      • Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television


      • View All Entertain­ment & Media
      • Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine


      • View All Health
      • Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories


      • View All Sports
      • Travel
      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry


      • View All Travel
  • Policy & Public Interest
      • Policy & Public Interest
      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety


      • View All Policy & Public Interest
  • People & Culture
      • People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women


      • View All People & Culture
  • Overview
  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO

      Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Log In
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • GDPR
  • News in Focus
    • Browse News Releases
    • Regulatory News
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Policy & Public Interest
    • Policy & Public Interest
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • People & Culture
    • People & Culture
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Log In
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • GDPR
  • Overview
  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®
  • Log In
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • GDPR
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Log In
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • GDPR

Newly-Published Study Finds Stretta Therapy for GERD Remains Highly Effective 10 Years After Treatment


News provided by

Mederi Therapeutics

24 Feb, 2014, 16:07 GMT

Share this article

Share this article


- Non-Surgical Procedure Offers Patients Significant Improvement in Symptoms and Elimination or Reduction in Medication, Along With a Regression of Barrett's Metaplasia

NORWALK, Connecticut, Feb. 24, 2014 /PRNewswire/ -- A newly-published peer-reviewed clinical study evaluated 217 patients pre-treatment and tracked them for ten years after receiving Stretta Therapy to treat gastroesophageal reflux disease (GERD). The study, entitled "Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later," is published in the online February edition of Surgical Endoscopy and highlights the long-term treatment outcomes of refractory GERD patients who received Stretta Therapy. In this study, the authors recognize the unmet need for treatment options in these 40 percent of GERD patients who do not adequately respond to medications, and assess the Stretta option for this underserved patient population. The study successfully reached all primary and secondary outcomes, with significant improvements in, GERD-health-related quality of life (HRQL) scores, patient satisfaction, and PPI use with results being durable at 10 years in the majority of patients. Additionally the study found a regression in Barrett's metaplasia, and no adverse effects of treatment, confirming the procedure's long-term safety.

Stretta Therapy is an outpatient, endoscopic treatment that delivers low levels of radiofrequency energy to the muscle between the stomach and esophagus, stimulating the muscle to grow and improving the barrier function to prevent reflux. (PRNewsFoto/Mederi Therapeutics Inc.) (PRNewsFoto/) (PRNewsFoto/)

(Logo: http://photos.prnewswire.com/prnh/20130211/NY56794 )

The long-term maintenance effects of Stretta seen in this study include:

  • Normalization of GERD HRQL scores was achieved in 72 percent of patients (primary endpoint 70 percent)
  • A 50 percent or greater reduction in PPI use occurred in 64 percent of patients - 41 percent eliminated PPIs entirely
  • The majority of patients remained satisfied with their Stretta  results at 10 years
  • Pre-existing Barrett's metaplasia regressed in 85 percent of biopsied patients, and no cases of esophageal cancer occurred

"This 10 year follow-up study confirms the findings of safety, efficacy and durability of Stretta that have been demonstrated in a multitude of other published studies since 2001," the study lead author, Mark Noar, MD, MPH of Endoscopic Microsurgery Associates PA, Heartburn & Reflux Study Center, stated. He noted that to date, there are 33 human subject clinical peer-reviewed published studies of Stretta, by 28 different study investigators, reporting on 2,400 patients which includes four randomized, controlled trials and three other longer term four year studies. "The outcomes of these studies, which were performed in various academic and community based facilities around the world, show a remarkable consistency of symptom improvements and reduction in acid exposure after Stretta," he said.

A review of this large body of clinical data earned Stretta the strongest grade recommendation in a Clinical Spotlight Review guideline from The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) in 2013.

Stretta studies have also shown the mechanism of action behind RF energy delivery as a reduction in transient relaxations of the lower esophageal sphincter muscle (LES), reduced tissue compliance without fibrosis, and a thickening of the sphincter muscle, improving barrier function and improving symptoms.

"What is so significant about this 10-year study is that it shows that Stretta meets the need for long-term and safe control of the underlying cause of reflux – without surgery," observed Dr. Noar. "Looking at this data in the context of other GERD treatments, patient satisfaction with Stretta is higher than with either long-term PPI use or anti-reflux surgery. Given concerns about long-term PPI use, the long-term durability of Stretta as seen in this study suggests this therapy as a way to correct reflux, reduce medication, and improve quality of life for these patients."

The Barrett's Esophagus Subset
In this study, patients with short segment Barrett's were included and in those available at 10 years for follow-up, 28 of 33 patients had no further dysplasia and/or metaplasia, and the remaining five had no progression of the disease. "This is the first study of its kind that has followed this type of patient for 10 years. The data clearly suggests that Stretta may provide a protective effect for the Barrett's tissue that could allow healing to occur," commented Dr. Noar. "Additionally because of the non-incidence of esophageal cancer at 10 years in these Barrett's patients, it raises the question of whether the reduction of reflux episodes as a result of Stretta helps limit the development of this growing condition in those with reflux."

For the published online study go to: http://link.springer.com/article/10.1007%2Fs00464-014-3461-6

ABOUT STRETTA®
Stretta is a minimally invasive treatment for GERD that is a proven safe and effective alternative to long-term drug therapy or anti-reflux surgery. Stretta involves delivery of RF to the LES and gastric cardia, offering a durable therapeutic option that does not preclude further steps with more invasive procedures if indicated. Many insurance plans cover Stretta.

ABOUT MEDERI®
Mederi Therapeutics manufactures Stretta and Secca – innovative medical devices that deliver RF energy to treat diseases of the digestive system. Mederi therapies are outpatient, minimally invasive, and are available worldwide.

For more information visit www.stretta-therapy.com.

Contact:
Julia Brannan
908-464-2470
julia@pascalecommunications.com

SOURCE Mederi Therapeutics

Modal title

    Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT

    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Worldwide Offices

    Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

    About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers

    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United States

    My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists

Contact PR Newswire


Products


About


My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2021 PR Newswire Europe Limited. All Rights Reserved. A Cision company.